North America Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Usage Pattern (Curative Care, Immunization, Other), Mode Of Administration (Skin, Circulatory/Muskoskeletal, Organs, Central Nervous System), Application (Autoimmune Disease, Hormonal Disorders, Orphan Diseases, Oncology, Others), End User (Hospitals and Clinics, Home Healthcare, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy), Country (U.S., Canada, Mexico, Rest of North America) – Industry Trends and Forecast to 2029
Market Analysis and Insights : North America Injectable Drug Delivery Market
The injectable drug delivery market is expected to witness market growth at a rate of 11.40% in the forecast period of 2022 to 2029. Data Bridge Market Research report on injectable drug delivery market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rapid advancements in the healthcare sector globally is escalating the growth of injectable drug delivery market.
Drug delivery is defined as the formulations, technologies, approaches, and systems that are used for carrying a pharmaceutical compound in the body. The injectable drug delivery devices include needle-free injectors, conventional syringes, auto-injectors, and pen injectors.
The surge in consumer awareness across the region acts as one of the major factors driving the growth of injectable drug delivery market. The rise in partnerships, collaborations and acquisitions, and increase in the use of the systems and devices in administering drugs in unconscious and comatose patients accelerate the market growth. The surge in popularity towards injectable drug delivery due to their advantage of a faster onset of action with high efficacy further influence the market. Additionally, investments to improve healthcare systems, advancement in technology, growing geriatric population and rise in health consciousness among consumers positively affects the injectable drug delivery market. Furthermore, advancements in nanotechnology and others extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
On the other hand, stringent regulatory systems and needle-stick injuries and infections are expected to obstruct the market growth. Product recalls are projected to challenge the injectable drug delivery market in the forecast period of 2022-2029.
This injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Injectable Drug Delivery Market Scope and Market Size
The injectable drug delivery market is segmented on the basis of type, usage pattern, mode of administration, application, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices, injectable drug delivery formulation. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
- On the basis of application, the injectable drug delivery market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology, others. The autoimmune diseases segment is further sub segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further sub segmented into diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
- On the basis of sage pattern, the injectable drug delivery market is segmented into curative care, immunization, other.
- On the basis of mode of administration, the injectable drug delivery market is segmented into skin, circulatory/muskoskeletal, organs, central nervous system.
- On the basis of end user, the injectable drug delivery market is segmented into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
- On the basis of distribution channel, the injectable drug delivery market is segmented into hospital pharmacy, pharmacy stores, direct tender and online pharmacy.
North America Injectable Drug Delivery Market Country Level Analysis
The injectable drug delivery market is analyzed and market size insights and trends are provided by country, type, usage pattern, mode of administration, application, end user and distribution channel as referenced above.
The countries covered in the North America injectable drug delivery market report are U.S., Canada and Mexico in North America.
U.S. dominates the North America injectable drug delivery market due to rising prevalence of diabetes in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The injectable drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and North America Injectable Drug Delivery Market Share Analysis
The injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related injectable drug delivery market.
Some of the major players operating in the injectable drug delivery market are Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among others.
SKU-